Insider · CIK 0001539067

Bagarazzi Mark

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001539067

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-03-05	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+27.6K sh	—	—	109,080
2019-03-05	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−8,408 sh	$3.61	−$30.4K	100,672
2019-03-05	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−27.6K sh	—	—	55,133
2018-03-10	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+20.4K sh	—	—	87,166
2018-03-10	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−5,653 sh	$4.51	−$25.5K	81,513
2018-03-10	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−20.4K sh	—	—	40,866
2018-03-09	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+25K sh	—	—	73,628
2018-03-09	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−6,896 sh	$4.51	−$31.1K	66,732
2018-03-09	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−25K sh	—	—	25,000
2018-03-05	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,333 sh	—	—	51,443
2018-03-05	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−2,815 sh	$4.29	−$12.1K	48,628
2018-03-05	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,333 sh	—	—	0
2018-03-05	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionA Award	Chief Medical Officer	AAward	+127K sh	—	—	126,500
2018-03-05	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+82.7K sh	—	—	82,700
2017-03-10	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Chief Medical Officer	AAward	+100K sh	$6.68	+$668K	100,000
2017-03-10	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+61.3K sh	—	—	61,300
2017-03-09	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+25K sh	—	—	50,758
2017-03-09	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−7,648 sh	$6.61	−$50.6K	43,110
2017-03-09	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−25K sh	—	—	50,000
2017-03-06	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−3,067 sh	$6.95	−$21.3K	25,758
2017-03-05	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,333 sh	—	—	28,825
2017-03-05	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,333 sh	—	—	8,333
2016-03-09	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionA Award	Chief Medical Officer	AAward	+67.5K sh	$7.02	+$474K	67,500
2016-03-09	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+75K sh	—	—	75,000
2016-03-07	INOINOVIO PHARMACEUTICALS, INC.F Tax Payment	Chief Medical Officer	FTax Payment	−2,842 sh	$7.48	−$21.3K	20,492
2016-03-05	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,334 sh	—	—	23,334
2016-03-05	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,334 sh	—	—	16,666
2015-03-05	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Chief Medical Officer	AAward	+60K sh	$7.56	+$454K	60,000
2015-03-05	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Chief Medical Officer	AAward	+25K sh	—	—	25,000
2014-03-26	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Chief Medical Officer	AAward	+150K sh	$3.23	+$485K	150,000
2013-04-16	INOINOVIO PHARMACEUTICALS, INC.P Purchase	Chief Medical Officer	PPurchase	+60K sh	$0.56	+$33.5K	60,000
2013-03-14	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Chief Medical Officer	AAward	+180K sh	$0.54	+$97.2K	180,000
2012-02-23	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Chief Medical Officer	AAward	+175K sh	$0.60	+$105K	175,000

Recent filings

Accepted (ET)
Mar 74
Bagarazzi Mark0001055726-19-000009
SEC(opens sec.gov)
Mar 134
Bagarazzi Mark0001055726-18-000011
SEC(opens sec.gov)
Mar 74
Bagarazzi Mark0001055726-18-000005
SEC(opens sec.gov)
Mar 134
INOVIO PHARMACEUTICALS, INC.0001055726-17-000009
SEC(opens sec.gov)
Mar 74
INOVIO PHARMACEUTICALS, INC.0001055726-17-000003
SEC(opens sec.gov)

Companies

INOVIO PHARMACEUTICALS, INC.Chief Medical OfficerINO

Address

11494 SORRENTO VALLEY ROAD SUITE A

SAN DIEGO, CA, 92121